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Abstract
Avian paramyxovirus (APMV) serotypes 1–9 have been isolated from many different avian species. APMV-1 (Newcastle
disease virus) is the only well-characterized serotype, because of the high morbidity, mortality, and economic loss caused by
highly virulent strains. Very little is known about the pathogenesis, replication, virulence, and tropism of the other APMV
serotypes. Here, this was evaluated for prototypes strains of APMV serotypes 2–9 in cell culture and in chickens and ducks.
In cell culture, only APMV-1, -3 and -5 induced syncytium formation. In chicken DF1 cells, APMV-3 replicated with an
efficiency approaching that of APMV-1, while APMV-2 and -5 replicated to lower, intermediate titers and the others were
much lower. Mean death time (MDT) assay in chicken eggs and intracerebral pathogenicity index (ICPI) test in 1-day-old SPF
chicks demonstrated that APMV types 2–9 were avirulent. Evaluation of replication in primary neuronal cells in vitro as well
as in the brains of 1-day-old chicks showed that, among types 2–9, only APMV-3 was neurotropic, although this virus was
not neurovirulent. Following intranasal infection of 1-day-old and 2-week-old chickens, replication of APMV types 2–9 was
mostly restricted to the respiratory tract, although APMV-3 was neuroinvasive and neurotropic (but not neurovirulent) and
also was found in the spleen. Experimental intranasal infection of 3-week-old mallard ducks with the APMVs did not
produce any clinical signs (even for APMV-1) and exhibited restricted viral replication of the APMVs (including APMV-1) to
the upper respiratory tract regardless of their isolation source, indicating avirulence of APMV types 1–9 in mallard ducks. The
link between the presence of a furin cleavage site in the F protein, syncytium formation, systemic spread, and virulence that
has been well-established with APMV-1 pathotypes was not evident with the other APMV serotypes.
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Introduction
The family Paramyxoviridae consists of enveloped viruses with
a nonsegmented, single-stranded, negative-sense RNA genome
[1]. These viruses have been isolated from a great variety of
mammalian and avian species around the world. Many members
of the family cause important human and animal diseases, while
the disease potential of many other members is not known. The
family is divided into two subfamilies: Paramyxovirinae and
Pneumovirinae. The subfamily Paramyxovirinae comprises five genera:
Rubulavirus, Respirovirus, Morbillivirus, Henipavirus, and Avulavirus.
Subfamily Pneumovirinae is divided into two genera: Pneumovirus and
Metapneumovirus. All paramyxoviruses isolated from avian species
are classified into the genus Avulavirus, except avian metapneumo-
viruses, which are classified in the genus Metapneumovirus. Avian
paramyxoviruses (APMVs) have been divided into nine different
serotypes (APMV 1 to 9) based on Hemagglutination Inhibition
(HI) and Neuraminidase Inhibition (NI) assays [2]. APMV-1
comprises all strains of Newcastle disease virus (NDV) and has
been well characterized because of its economic importance in
poultry industry. As an initial step towards characterizing other
APMV serotypes, complete genome sequences of one or more
representative strains of APMV serotypes 2 to 9 have been
determined [3–10].
The genomes of all paramyxoviruses range between 15 and
19 kb in length and contain 6–10 genes that encode up to 12
different proteins [11]. For members of subfamily Paramyxovirinae,
efficient RNA replication requires that the nucleotide (nt) length of
the genome is an even multiple of six, known as ‘rule of six’,
reflecting the precise packaging of the polynucleotide in the
nucleocapsid [12]. The genomes of APMVs are very similar in
organization. All the members contain six genes in the order of 39-
N-P-M-F-HN-L-59 with the exception of APMV-6, which contains
an additional small hydrophobic protein (SH) gene in its genome.
APMVs encode a nucleocapsid protein (N), a phosphoprotein (P),
a matrix protein (M), a fusion protein (F), a hemagglutinin-
neuraminidase protein (HN), and a large polymerase protein (L).
Two additional proteins called, V and W, are produced by RNA
editing of the P gene. The F and HN proteins form spike-like
projections on the outer surface of the viral envelope and are the
neutralizing and protective antigens of NDV. Significant sequence
divergence in these two proteins exists among APMV serotypes
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dase activity; whereas, the F protein is directly involved in
membrane fusion which is necessary for the entry of the virus.
Homotypic interactions between the HN and F proteins are
hypothesized to control initiation of the fusion process for most
paramyxoviruses [13,14]. The M protein forms the inner layer of
the envelope and plays a key role in assembly by interacting with
the HN and F proteins as well as ribonucleocapsid [15,16].
APMVs have been isolated from many different avian hosts
[17]. APMV-1 is the only well-characterized serotype, because of
the high morbidity, mortality, and economic loss caused by highly
virulent strains. NDV isolates vary greatly in their pathogenicity
for chickens, ranging from no apparent disease to severe
respiratory and neurological disease causing 100% mortality
[18]. NDV strains are categorized into three main pathotypes:
lentogenic (avirulent), mesogenic (moderately virulent), and
velogenic (virulent), based on their pathogenicity in chickens
[19]. In contrast, the disease potential of APMV-2 to -9 is not well
known because many of these viruses were isolated from birds
dying in quarantine, hunter killed, trapped wild birds, apparently
healthy poultry or exotic birds [20]. APMV-2 and -3 have been
reported to cause significant disease in poultry, whereas the
pathogenic potential of APMV-4 to -9 is generally unknown. In
general, APMV-2 strains have been isolated from chickens, turkeys
and wild birds across the globe and have been found to cause mild
respiratory disease, decreases in egg production, and infertility
[21–23]. APMV-3 strains have been isolated from wild and
domestic birds and their infections have been associated with
encephalitis and high mortality in caged birds [24]. APMV-5
strains have only been isolated from budgerigars (Melopsittacus
undulatus) and cause depression, dyspnoea, diarrhea, torticollis, and
acute fatal enteritis in immature budgerigars, leading to very high
mortality [25]. Infections from APMV-4, -8, and -9 appear to be
restricted to ducks and geese. APMV-6 and -7 infections in turkeys
cause drops in egg production and induce respiratory disease.
There are no reports of isolation of APMV-5, -8 and -9 from
poultry [2]. But recent serosurveillance of commercial poultry
farms in the U.S. indicated the possible prevalence of all APMV
serotypes excluding APMV-5 in chickens [26]. The pathogenicity
of APMV-2 and APMV-3 has been studied in experimentally
infected chickens [27,28]. However, replication, pathogenicity,
and neurovirulence of APMV serotypes 2 through 9 have not been
comprehensively studied. Therefore, we characterized in vitro
replication of APMVs (growth kinetics and cytopatic effect in
chicken fibroblast cells) and their in vivo replication and tropisms by
infecting prototype strains of each serotype in two different ages of
chickens (1-day-old and 2-week-old chickens) and 3-week-old
ducks. Specifically, neurotropism of APMVs was evaluated in
primary chicken neuronal cells and brain tissue of 1-day-old
chicks.
Materials and Methods
2.1 Cells and Viruses
The chicken embryo fibroblast cell line (DF1, ATCC,
Manassas, VA, USA) was grown in Dulbecco’s minimal essential
medium (DMEM) with 10% fetal bovine serum (FBS) and
maintained in DMEM with 5% FBS. The African green monkey
kidney Vero cell line (ATCC, Manassas, VA, USA) was grown in
Eagle’s minimum essential medium (EMEM) containing 10% FBS
and maintained in EMEM with 5% FBS. Primary chicken
neuronal cells were grown in Neurobasal medium with B-27
supplement (Invitrogen).
The viruses used in this study were nine prototype strains of
APMV serotypes 1 to 9: APMV-1 (NDV), lentogenic strain
LaSota/46 and mesogenic strain Beaudette C (BC); APMV-2,
APMV-2/Chicken/California/Yucaipa/56; APMV-3, APMV-3/
PKT/Netherland/449/75; APMV-4, APMV-4/duck/Hon-
gKong/D3/75; APMV-5, APMV-5/budgerigar/Kunitachi/74;
APMV-6, APMV-6/duck/HongKong/18/199/77; APMV-7,
APMV-7/dove/Tennessee/4/75; APMV-8, APMV-8/goose/
Delaware/1053/76; and APMV-9, APMV-9/duck/New York/
22/1978. All of the viruses were grown in 9-day-old embryonated
specific-pathogen-free (SPF) chicken eggs inoculated by the
allantoic route, except for APMV-5, which was grown in Vero
cells. The ability of viruses to produce plaques was tested on Vero
and DF1 cells under 0.8% methylcellulose overlay. Exogenous
protease was supplemented into the cells for replication of APMV-
1 LaSota, APMV-3 and -9 (10% allantoic fluid) and APMV-8
(1 mg/ml of acetyl trypsin) (4, 9, 10). The monolayers were fixed
with methanol and plaques were visualized by immunoperoxidase
staining using virus specific antiserum raised against N protein.
Virus titers for in vitro and in vivo replication were quantified by
immunoperoxidase staining with N-specific antibodies on DF1
cells (APMV-1, -2, -3, -4, -6, and -9) or Vero cells (APMV-5, -7,
and -8) [3–10].
2.2. Growth Characteristics of APMVs
The multicycle growth kinetics of the viruses was evaluated in
DF1 cells. Duplicate wells of six-well plates were infected with each
APMV at an MOI of 0.01 PFU/cell. After 1 h of adsorption, the
cells were washed and then covered with DMEM containing 2%
FBS at 37uCi n5 %C O 2. APMV-1 LaSota, APMV-3, -8, and -9
were supplemented with protease, as described above. Super-
natants were collected and replaced with an equal volume of fresh
medium at 12-h intervals until 72 h post-infection (hpi). Virus
titers in the collected supernatants were quantified in DF1 cells or
Vero cells by limiting dilution and immunostaining with N-specific
antibodies [29–30]. Virus titers were expressed as 50% tissue
culture infectious dose (TCID50/ml) by the end-point method of
Reed and Muench [31].
2.3. Mean Death Time and Intracerebral Pathogenicity
Index Tests
The pathogenicity of APMVs was determined by the mean
death time (MDT) test in 9-day-old SPF embryonated chicken
eggs and by the intracerebral pathogenicity index (ICPI) test in
1-day-old SPF chicks [19]. Briefly, for the MDT, a series of 10-
fold dilutions of infected allantoic fluid (0.1 ml) was inoculated
into the allantoic cavities of five 9-day-old eggs per dilution and
incubated at 37uC. The eggs were examined once every 8 h for
7 days, and the time of embryo death was recorded. The MDT
was determined as mean time (h) for the minimum lethal dose
of virus to kill all the inoculated embryos. The criteria for
classifying the virulence of NDV isolates are: ,60 h, virulent
strains; 60 to 90 h, intermediate virulent strains; and .90 h,
avirulent strains. For the ICPI test, 0.05 ml of a 1:10 dilution of
fresh infective allantoic fluid for each virus was inoculated into
group of 10 1-day-old SPF chicks via the intracerebral route.
The birds were observed for clinical symptoms and mortality
once every 8 h for a period of 10 days. At each observation, the
birds were scored as follows: 0 if normal; 1 if sick; and 2 if
dead. The ICPI is the mean of the score per bird per
observation over the 8-day period. Highly virulent velogenic
viruses give values approaching 2, and avirulent or lentogenic
strains give values at or close to 0. All experiments involving
experimental animals were approved by the committee of
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and conducted following the guidelines.
2.4. Neurotropism of APMVs in vitro and in vivo
To evaluate neurotropism of APMVs in vitro, primary chicken
neuronal cells were prepared from 9-day-old chicken embryos for
virus infection. Briefly, the section of hippocampus was dissected
from embryos, digested with trypsin, passed through a cell strainer
(40 mm nylon), seeded onto poly-L-lysine-coated plates, and then
infected with each virus [32]. Spread of viruses in neuronal cells
was determined by confocal microscopy analysis. Briefly, at
48 hpi, the cells were fixed, permeabilized, stained with polyclonal
antibodies against the respective N protein and a neuronal marker
(anti-neuron specific beta III tubulin antibody, abcamH, Cam-
bridge, MA) followed by anti-Alexa Fluor 488 and 594 antibodies,
and then analyzed by confocal microscopy. In addition, virus
replication in neuronal cells was determined by collecting super-
natants at 12-h intervals until 72 hpi. Virus titers in the collected
supernatants were quantified in DF1 or Vero cells by limiting
dilution and immunostaining with N-specific antibodies as
described above.
To evaluate the ability of APMVs to replicate in chicken brains,
ten 1-day-old SPF chicks were inoculated with 0.05 ml of a 1:10
dilution of fresh infective allantoic fluid for each virus via the
intracerebral route. Two birds were sacrificed daily until 5 days
post-infection (dpi). Brain tissue samples were collected from the
sacrificed birds and processed for immunohistochemistry as
described later. Brain tissue samples also were homogenized and
virus titers were determined by limiting dilution and immunoper-
oxidase assay in DF1 cells or Vero cells using polyclonal antibodies
against the respective N protein.
2.5. Replication of APMVs in 1-day-old Chicks, 2-week-old
Chickens, and 3-week-old Ducks Following Intranasal
Inoculation
Three 1-day-old chicks per group were inoculated with
100 ml of each virus (256 HA units/bird) via the intranasal
route. On day 3 post-infection, tissue samples (lung, trachea,
spleen, and brain) were collected for virus titration by limiting
dilution and immunoperoxidase assay as described above. To
evaluate the tropism of APMVs in older birds, groups of ten 2-
week-old SPF chickens were inoculated with 200 ml of each
virus (256 HA units/bird) by the intranasal route. Three birds
from each group were sacrificed at 4 dpi and tissues samples
(lung, trachea, spleen, and brain) were collected and processed
for immunohistochemistry as described later. Tissue samples
also were homogenized for virus titration. Virus titers in DF1 or
Vero cells were determined by limiting dilution as described
above. To confirm the replication of viruses in infected birds,
the tissue samples were also inoculated into 9-day-old
embryonated chicken eggs. On 3 dpi, virus growth was
determined by HA assay. The remaining birds were observed
daily for 10 days for any clinical signs and then sacrificed for
virus titration of various tissues as described above. To evaluate
virus replication in different hosts, we further determined
replication of APMVs in 3-week-old mallard ducks. Six birds
each were infected with 500 ml of individual APMVs (256 HA
units/bird) via the combined intranasal and intratracheal routes
and sacrificed at 4 dpi for collection of tissue samples (lung,
trachea, spleen, and brain). Homogenates were prepared for
virus titration in cell cultures and replication in eggs as
described above. The remaining birds were observed daily for
10 days for any clinical signs.
2.6. Histopathology and Immunohistochemistry
From the experiments described above, brain tissue harvested
3 dpi from 1-day-old chicks infected by intracerebral route and
various tissue samples harvested 4 dpi from 2-week-old chickens
infected by the intranasal route were fixed in phosphate-buffered
formalin (10%). Fixed tissues were embedded in paraffin and
sectioned (Histoserv, Inc., Germantown, MD). Sections from
mock-infected birds were used as controls. The tissues were
deparaffinized, rehydrated, and subsequently, immunostained to
detect viral N protein using the following protocol. Briefly, the
sections were blocked with 1% BSA in PBS for 1 h at room
temperature, incubated with a polyclonal antibody (1:200 dilution)
against the respective N protein (29, 30) followed by horseradish
peroxidase-conjugated goat anti-rabbit antibodies for 30 min, and
then stained with AEC (3-amino-9-ethylcarbazole) substrate-
chromogen.
Results
3.1. Cytopathic Effect of APMVs in Cell Culture
Syncytium formation is a hallmark of the cytopathic effect
(CPE) caused by many paramyxoviruses, including APMV-1, in
cell culture [1]. To investigate syncytium formation by APMV
serotypes 2–9 and to compare their CPE, Vero cells were infected
with mesogenic APMV-1 strain BC or with representatives of the
other APMV serotypes at a multiplicity of infection (MOI) of
0.1 PFU/cell, incubated for 48 h, and visualized directly by
photomicroscopy (data not shown) and following immunostaining
with rabbit antiserum to the respective N protein (Fig. 1).
Exogenous protease was supplemented into the culture medium
for replication of APMV-3, 8, and 9, based on our previous studies
[4,9,10]. APMV-1 strain BC was known to be independent of
protease supplementation. APMV-3 and -5 produced distinctive
CPE with syncytium formation similar to those of APMV-1. In
contrast, the rest of APMVs produced single cell infections leading
to cell rounding and detachment of infected cells but a lack of
evident syncytia. Similar results were observed in chicken embryo
fibroblast DF1 cells (data not shown).
3.2. Growth Characteristics of APMVs in DF1 Cells
We further evaluated the multicycle replication of the APMVs
in DF1 cells (Fig. 2). There was a great difference in the kinetics
and magnitude of replication among different APMVs. APMV-1
strain BC and APMV-1 lentogenic strain LaSota grew better than
any other APMVs and reached the highest titers (10
8 TCID50/ml)
at 32 and 60 hpi, respectively. APMV-3 replicated relatively well,
reaching 10
7 TCID50/ml at 72 hpi. The highest titers of APMV-2
and -5 also were detected at 72 hpi, but their titers were 4.0 log10
lower than those of APMV-1. In general, replication of other
APMV viruses was limited in DF1 cells (,10
2 TCID50/ml).
Inefficient virus replication in vitro (i.e., APMV-4, 6, 7, 8, and -9)
was correlated with the pattern of a single-cell infection as
observed with CPE in infected cells (Fig. 1).
3.3. Evaluation of Pathogenicity of APMVs in Chickens by
MDT and ICPI Tests
The pathogenicity of APMVs was evaluated with the standard
pathogenicity tests used for APMV-1, namely MDT in embryo-
nated chicken eggs and ICPI in 1-day-old chicks (Table 1). The
pathogenicity of the two strains of APMV-1 has been well
characterized: strain BC is neurovirulent (MDT 58 h and ICPI
1.55), whereas strain LaSota is avirulent (MDT 112 h and ICPI
0.00) and is used as a vaccine strain. For the most part, APMV 2–9
were even more avirulent based on these assays than strain
Pathogenicity of APMVs in Chickens and Ducks
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was APMV-3, which had a MDT value (117 h) that is similar to
that of the LaSota strain, but had an ICPI value (0.53) that was
higher than that of the LaSota strain (0.00), but nonetheless
remained in the avirulent range. The MDT and ICPI values of
other APMVs were .144 h and 0.00, respectively, consistent with
being avirulent. Chicks infected with APMV serotypes 2–9 had no
apparent clinical signs during the 8-day period of the ICPI test.
3.4. Replication of APMVs in Neuronal Cells and in the
Brains of 1-day-old Chicks
To evaluate neurotropism of APMVs, virus replication was
evaluated in primary chicken neuronal cells in vitro. We first
evaluated infection (MOI of 0.1 PFU) in neuronal cells by confocal
microscopy analysis of cells that had been immunostained at
72 hpi with N protein against each respective APMV (Fig. 3A).
Expression of the N protein of APMV-1 strain BC was clearly
detected in dendrites and axons. In contrast, APMV-1 strain
LaSota failed to replicate in neuronal cells even after supplemen-
tation with allantoic fluid as a source of protease. Among serotypes
2–9, APMV-3 was able to replicate well without the addition of
allantoic fluid, whereas the presence of APMV-7 and -8 antigens
in infected cells was sporadically detected. Replication of the other
APMVs was not detected up to 3 dpi. We also examined
replication in the neuronal cell cultures by collecting supernatants
from the cultures at 12 h intervals and assaying for infectious virus
by titration. This confirmed the ability of APMV-3 to replicate in
neuronal cells, although its titer was lower than that of
neurovirulent APMV-1 strain BC (Fig. 3B). Titers of BC and
APMV-3 in neuronal cells increased gradually and reached 5.5
and 3 log TCID50/ml, respectively, at 72 hpi. In contrast, other
APMVs, including APMV-1 strain LaSota, were not detected in
the supernatants of neuronal cells, indicating their inability to
replicate in these cultures of primary chicken neuronal cells.
We further determined the ability of the APMV serotypes to
replicate in chicken brains by inoculating 1-day-old chicks via the
intracerebral route. The infected chickens were sacrificed daily
and brain tissue was collected for virus titration (Fig. 4). In chicks
infected with neurovirulent APMV-1 strain BC, the virus reached
the highest titer (.6.0 log10 TCID50/g) in the brain at 2 dpi,
resulting in the death of all of the infected chicks on 3 dpi. The
non-neurovirulent LaSota strain was detected at low titer on day 1,
but was not detected on subsequent days and did not cause disease
Figure 1. Cytopathic effect in Vero cells infected with avian paramyxoviruses (APMVs). Vero cells in six-well plates were infected with
each of APMVs at a multiplicity of infection (MOI) of 0.1 PFU/cell and incubated for 48 h. Exogenous protease was provided in the case of APMV-3, -8,
and -9 (Materials and Methods). The viral plaques in the infected cells were visualized by immunoperoxidase staining using polyclonal antibodies
raised against the N protein of the respective APMV.
doi:10.1371/journal.pone.0034927.g001
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a titer of 5 log10 TCID50/g on 3 dpi, but did not cause disease or
death of any of the infected chicks during the 5 days of
observation. We detected a low level of replication of APMV-8
(,2 log10 TCID50/g), with no observed disease or death.
Replication of the other APMVs was not detectable on any day,
and there was no detectable disease or death. Thus, APMV-3 was
identified as the only neurotropic virus among APMV serotypes 2–
9. However, despite the ability of APMV-3 to replicate to
moderate titer in the brain, it did not cause discernable disease or
death and thus was non-neurovirulent.
The neurotropism of the APMVs in 1-day old chicks also was
evaluated by immunohistochemistry analysis of brain tissue
harvested on day 3 (Fig. 5). Viral antigens were detected in the
brain tissues that had been infected with APMV-1 strain BC and
APMV-3, confirming the replication of the two viruses in chicken
brain. Our result showed a more extensive distribution of viral
antigens in brain tissue infected with BC compared to APMV-3. In
contrast, presence of viral antigens was not detected in the brain
tissues that had been infected with the other APMVs (Fig. 5).
3.5. Replication of APMVs in Chickens and Ducks
We next determined the replication and tissue tropism of
APMVs in 1-day-old and 2-week-old chickens following intranasal
inoculation. Chickens were sacrificed on 3 dpi for 1-day-old chicks
and on 4 dpi for 2-week-old chickens, and the following tissues
were harvested for quantitative virology: trachea, lungs, spleen,
and brain (Fig. 6). In 1-day-old chicks, APMV-1 strain BC
replicated to high titers (.5.0 log10 TCID50/g) in each of the
sampled tissues in each of the birds, whereas LaSota replicated in
trachea, lung and spleen, but not the brain, and its titers were less
than those of BC (Fig. 6A). APMV-3 replicated to moderate titers
(.4.0 log10 TCID50/g) in all of the collected samples, including
the brain. However, replication of other APMVs was restricted to
the trachea, and their titers were low, ranging from 1.5 to 3 log10
TCID50/g (data for APMV-2 are shown in Fig. 6A; the other
serotypes are not shown). Chicks infected with APMV-1 strain BC
began to show clinical signs on 1 dpi and distinctive neurological
signs on 2 dpi, whereas chicks infected with other APMVs had no
apparent clinical signs during the 3-day post-infection.
Figure 2. In vitro growth characterization of APMVs in chicken embryo fibroblast DF1 cells. Part A shows APMV-1 to -4, and Part B shows
APMV-5 to -9. The growth characteristics of the APMVs were determined by multicycle growth curve in DF1 cells infected with an MOI of 0.01 PFU/
cell. Exogenous protease was provided in the case of APMV-1 LaSota and APMV-3, -8, and -9 (Materials and Methods). The viral titers were determined
by limiting dilution on DF1 or Vero cells and immunostaining with polyclonal antibodies raised against the respective N protein.
doi:10.1371/journal.pone.0034927.g002
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and viral titers were lower compared to 1-day-old chickens
(Fig. 6B). APMV-1 strain BC was able to replicate in all of the
collected tissues, but the virus titers in the brains of older birds (2.6
log10 TCID50/g) were much lower than that of 1-day-old chickens
(6.5 log10 TCID50/g). APMV-1 strain LaSota replicated in the
trachea, lungs, and spleen, but not the brain, as was observed in
the 1-day-old chickens. Interestingly, APMV-3 replication was
detected only in the trachea and the brain, indicating that it is
neutrotropic in these older chickens despite this restricted
replication. APMV-2 was also able to replicate in trachea of 2-
week-old chickens. However, replication of the other APMVs was
not detected in any of the harvested tissue samples. Since APMV
2–9 can replicate much better in embryonated chicken eggs than
in cell culture [20], the collected tissue homogenates from this
same experiment also were inoculated into 9-day-old embryonated
chicken eggs to confirm the replication of viruses in various tissues
(Table 2; APMV-5 was not assayed because it does not replicate in
the allantoic cavity of chicken eggs). This approach with increased
sensitivity enabled us to detect replication of all of the tested
APMVs in the trachea of most of the birds. In addition, APMV-2,
3, 6, 7, and 9 were detected in the lungs of at least one of the three
chickens in each group, and APMV-3 was detected in the spleen of
two chickens. Among the tested APMVs, APMV-4 showed the
least replication in chickens both in vitro and in vivo (Fig. 2 and
Table 2), suggesting that it has a strong host range restriction in
chickens. On 10 dpi, none of the APMVs were detected in any of
the sampled tissues from any of the birds (not shown). Clinical
signs of illnesses in any of the infected groups were not found up to
10 dpi.
Histopathological examinations of tissue samples collected on
4 dpi revealed similar microscopic findings in all APMVs.
Specifically, the trachea showed mild lymphocytic tracheitis, mild
to moderate multifocal mucosal attenuation, and loss of tracheal
alveolar mucous glands (Fig. 7A). Lung sections exhibit moderate,
multifocal, lymphocytic to lymphohistiocytic bronchitis with mild
to moderate perivascular and peribronchial interstitial inflamma-
tion and focal perivascular cuffing with varying severity (Fig. 7B).
Minimal lymphoid depletion was detected in the spleen, and
microscopic lesions were not found in any of the brain tissues (data
not shown). The presence of virus antigens in various tissues of
infected chickens was further evaluated by immunohistochemistry
analysis. Deparaffinized sections of the virus-infected and un-
infected control tissue were immunostained using polyclonal
antibodies against the N protein of the respective APMV. The
presence of antigens for most APMVs was detected in the
epithelial lining of trachea (Fig. 7C). However, no antigen was
detected in any tissues harvested from chickens infected with
APMV-5. In the lungs, the viral antigens were mostly localized in
the epithelium surrounding the medium and small bronchi
(Fig. 7D). Lung tissues showed extensive presence of antigens for
APMV-1 strain BC followed by APMV-1 strain LaSota, APMV-3,
and APMV-2. However, presence of antigens for other serotypes
was not detected in lung tissues. Our results suggested that APMV
2–9 were avirulent, and their replication was mostly restricted to
trachea and lungs of infected chickens.
Since several of the specific APMV strains under evaluation (i.e.,
APMV-4, -6, and -9) were isolated from other avian species
including the mallard duck (see Table 1), their replication and
pathogenicity were further evaluated in groups of 3-week-old
ducks following intranasal inoculation. No clinical signs of illnesses
in any of the infected groups were found up to 10 dpi. Three birds
from each group were sacrificed on 4 dpi and the tissues were
harvested for virus titration. None of the APMVs were detected in
any of the tested tissues from any of the ducks by virus titration in
DF1 cells (data not shown). However, APMVs were detected in
some of the samples of trachea, lung, and spleens by inoculation
into 9-day-old embryonated chicken eggs, although none of the
APMVs (including APMV-1) were detected in any of the brain
samples (Table 3; APMV-5 was not evaluated). APMV-1 strains
BC and LaSota were the only APMVs that were detected in all
three ducks in their respective groups, although replication was
mostly restricted to the trachea. APMV-2 was found only in the
trachea of a single duck, in contrast to its more efficient replication
in chickens. APMV-3 was not detected in any samples from any
duck, in contrast to its efficient replication and neurotropism in
chickens. APMV-8 and -9 also were not detected in any duck. The
other serotypes (APMV-4, -6, and -7) were each detected in the
trachea of two ducks from its group, and in the lungs of one or two
ducks from its group. APMV-4 replicated slightly better in ducks
Table 1. Pathogenicity of avian paramyxoviruses (APMVs) in embryonated eggs and chicks.
Pathogenicity
Virus Strain Isolation source Fusion protein cleavage site MDT
a ICPI
b
APMV-1 BC Chicken RRQKRQF 58 h 1.55
APMV-1 LaSota Chicken GRQGRQL 112 h 0.00
APMV-2 Yucaipa Chicken KPASRQF .144 h 0.00
APMV-3 Netherlands Parakeet RPRGRQL 117 h 0.53
APMV-4 Hong Kong Duck DIQPRQF .144 h 0.00
APMV-5 Kunitachi Budgerigar KRKKRQF .144 h 0.00
APMV-6 Hong Kong Duck APEPRQL .144 h 0.00
APMV-7 Tennessee Dove LPSSRQF .144 h 0.00
APMV-8 Delaware Goose YPQTRQL .144 h 0.00
APMV-9 New York Duck IREGRQI .144 h 0.00
aMean embryo death time (MDT): the mean time (h) for the minimum lethal dose of virus to kill all of the inoculated embryos. Pathotype definition for APMV-1: virulent
strains, ,60 h; intermediate virulent strains, 60 to 90 h; avirulent strains, .90 h.
bIntracerbral pathogenicity index (ICPI): evaluation of disease and death following intracerebral inoculation in 1-day-old SPF chicks. Pathotype definition: virulent strains,
1.5–2.0; intermediate virulent strains, 0.7–1.5; and avirulent strains, 0.0–0.7.
doi:10.1371/journal.pone.0034927.t001
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spleen (of a single duck), whereas it had not been detected in the
spleen of infected chickens. Thus, the pattern of infection in
chickens and ducks was substantially different and could not be
predicted by the isolation history.
Discussion
APMVs are frequently isolated from a wide variety of avian
species and are grouped into nine serotypes based on antigenic
analysis [33], with a likely tenth serotype recently described in
Figure 3. Replication of APMVs in primary chicken neuronal cells. Neuronal cells were infected with APMVs at an MOI of 0.1. (A) In 48 hpi,
the cells were fixed with 4% paraformaldehyde, permeabilized with 0.2% Triton X-100, stained with a neuronal marker (anti-neuron specific beta III
tubulin antibody) and polyclonal antibodies against the N protein followed by anti-Alexa Fluor 488 and 596, and then analyzed by confocal
microscopy. The neuronal maker and viral N proteins stained red and green, respectively. (B) Virus replication in neuronal cells was determined by
collecting the supernatants every 12 h. The viral titers were determined by limiting dilution on DF1 or Vero cells and immunostaining with polyclonal
antibodies against the respective N protein.
doi:10.1371/journal.pone.0034927.g003
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1 (NDV) is the most extensively characterized member of the
APMV serotypes. APMV-2 to -9 have been isolated from both
wild and domestic birds, but their disease potential in wild or
domestic birds was largely unknown. APMV-1 also has been
shown to infect a number of non-avian species [35] and presently
is being evaluated as a potential human vaccine vector for human
pathogens [36]. There is a possibility that APMV-2 to -9 could
also be used as human vaccine vectors for human pathogens,
providing multiple vectors with minimal cross-restriction from
vector-specific immunity. Our previous studies demonstrated that
APMV-2 to -9 can replicate in mammalian hosts, specifically in
the hamster and mouse models [29,30]. However, their replication
and pathogenicity in avian host has not been comprehensively
Figure 4. Growth kinetics of APMVs in the brains of infected 1-day-old chicks. Ten 1-day-old SPF chicks were inoculated with APMVs via
the intracerebral route. Two birds in each group were sacrificed daily until 5 dpi. The virus titers in the collected samples were determined by limiting
dilution in DF1 cells and immunostaining with polyclonal antibodies raised against the respective N protein.
doi:10.1371/journal.pone.0034927.g004
Figure 5. Detection of viral antigens of APMVs in the brains of infected 1-day-old chicks by immunohistochemistry. Chicks were
inoculated with each virus by the intracerebral route, and brain tissue was harvested for immunohistopathology on 3 dpi. The tissues were fixed in
phosphate-buffered formalin, and sections were prepared and stained using an antibody against the respective N protein (stained red).
doi:10.1371/journal.pone.0034927.g005
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in vitro and in vivo replication and pathogenicity of APMVs in
chickens and their in vivo replication and pathogenicity in ducks
and characterized differences in their tropisms, including neuro-
tropism in chickens.
Virulent APMV-1 strains contain a multibasic cleavage site
(with the general consensus sequence of RRQKRQF) with
a polybasic furin motif (RX[R/K]RQ) that is readily cleaved in
cell culture by intracellular furin or furin-like protease. Avirulent
APMV-1 strains lack this polybasic site and depend on
extracellular protease for cleavage, which in vitro can be supplied
by exogenous protease and in vivo is supplied by secretory trypsin-
like protease found in the lumen of the respiratory and enteric
tracts [20]. Our study showed that APMV-1 strain BC readily
forms syncytia in cell culture and replicates more efficiently in vitro
than any of the other APMVs, followed by the APMV-1 LaSota
strain. Characterization of the CPE of APMV types 2–9
demonstrated that only APMV-3 and -5 induced syncytium
formation in infected cells. The cleavage site of APMV-3
(RPRGRQL) lacks the furin motif, and efficient growth and
syncytium formation depended on supplementation with exoge-
nous protease, resembling an avirulent APMV-1 strain. The
cleavage site of APMV-5 (KRKKRQF) is the only example from
APMV2–9 to have a furin motif [6], and syncytium formation and
growth were independent of added protease, resembling a virulent
APMV-1 strain. Production of syncytia by APMV-3 and APMV-5
correlated with efficient multicycle replication in cell culture in the
case of APMV-3 and a moderate level of replication in cell culture
in the case of APMV-5. Although APMV-5 contains the greatest
number of basic residues for any of the APMV except for some
strains of APMV-1, its replication in DF1 cells was much less
efficient compared to APMV-1 and -3. Interestingly, the level of
replication of APMV-5 in cell culture was very similar to that of
APMV-2, which lacks a furin motif (KPASRQF), does not form
Figure 6. Replication of APMVs in 1-day- and 2-week-old chickens. Groups of (A) 1-day- or (B) 2-week-old chickens were inoculated with
each virus (256 HA units) by the intranasal route. Three birds from each group were sacrificed on 3 dpi (1-day-old chicks) or 4 dpi (2-week-old
chickens), and virus titers in the collected tissues samples (brain, trachea, lung, and spleen) were determined by limiting dilution in DF1 cells and
immunostaining with polyclonal antibodies raised against the respective N protein.
doi:10.1371/journal.pone.0034927.g006
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are independent of exogenous protease. Thus, for those two
viruses (APMV-2 and -5), the growth phenotype in cell culture did
not correlate well with the presence or absence of a furin motif in
the cleavage sequence. The other APMVs (types 4, 6, 7, 8, and 9)
have one or two basic amino acids in their cleavage site sequences
and exhibited single cell infection and inefficient replication in vitro.
However, only in the case of serotypes 8 and 9 did the addition of
exogenous protease increase the efficiency of replication, and the
overall level of replication remained very low and syncytia were
not observed. Thus, APMV types 2, 4, 6, 7, 8, and 9 have cleavage
sites that seemed similar to those of avirulent APMV-1 strains, but
the inclusion of protease had little effect on growth in cell culture.
The pathogenicity of APMVs was first characterized by
standard pathogenicity tests, namely the ICPI and MDT assays.
We included two well-characterized strains of APMV-1, meso-
genic BC and lentogenic LaSota, and compared their pathoge-
nicity with that of APMV serotypes 2–9. This showed that APMV
serotypes 2–9 were avirulent by both assays. Of types 2–9, only
APMV-3 was associated with embryo death in the MTD assay and
disease in the ICPI assay, although these effects were modest and
APMV-3 was categorized as avirulent by the standards of these
assays. By the MDT assay, the other types (types 2, 4, 5, 6, 7, 8,
and 9) lacked detectable virulence and thus were less virulent than
the well-known avirulent vaccine strain APMV-1 LaSota, and by
the ICPI assay these APMVs were equivalent to LaSota in lacking
detectable virulence. Thus, possession of a furin cleavage site and
the ability to form syncytia by APMV-5 did not correlate with
virulence in vivo, nor did the ability of APMV-2 to replicate to
moderate titers in cell culture without the addition of trypsin.
We investigated the neurotropism of APMVs in chicken
neuronal cells in vitro and in the brains of 1-day-old chicks infected
via the intracerebral route. The neurovirulent APMV-1 strain BC
was observed to replicate in chicken neuronal cells both on the
basis of antigen expression and the production of infectious virus.
In contrast, the non-neurovirulent LaSota strain did not detectably
express viral antigens in these cells, and infectious virus was
detected in the culture only at a low level on a single day early in
Table 2. Replication of APMVs in 2-week-old chickens.
Virus Virus replication in embryonated eggs
a
Brain Trachea Lung Spleen
APMV-1 (BC) 3/3 3/3 3/3 3/3
APMV-1 (LaSota) 0/3 3/3 3/3 3/3
APMV-2 0/3 3/3 2/3 0/3
APMV-3 2/3 3/3 3/3 2/3
APMV-4 0/3 1/3 0/3 0/3
APMV-6 0/3 2/3 1/3 0/3
APMV-7 0/3 3/3 2/3 0/3
APMV-8 0/3 2/3 0/3 0/3
APMV-9 0/3 3/3 1/3 0/3
aGroups of 2-week-old chickens were inoculated with each virus by the
intranasal route. Three birds from each group were sacrificed on day 4, and
tissues samples (brain, trachea, lung, and spleen) were collected and
homogenized. To confirm the virus replication, each sample (100 ml) in the
collected samples was inoculated into three eggs, and allantoic fluids were
collected on 3 dpi. Virus replication was determined by hemagglutination
assay. Note that APMV-5 was not analyzed because it does not replicate in the
allantoic cavity of chicken eggs.
doi:10.1371/journal.pone.0034927.t002
Figure 7. Histopathology and immunohistochemistry in sec-
tions of collected tissues from 2-week-old chickens infected
with APMVs. Chickens were inoculated with each virus (256 HA units)
by the intranasal route, and tissue samples were harvested on 4 dpi.
The tissues were fixed in phosphate-buffered formalin and sections
were prepared and stained with hematoxylin and eosin for histopa-
thology (A and B) or antibodies against the respective N protein for
immunohistochemistry, which stained red (C and D). Histopathological
examinations of tissue samples revealed similar microscopic findings in
all APMVs. The trachea (A) showed mild lymphocytic tracheitis, mild to
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neuronal cells was detected only with APMV-3, -7, and -8, and
production of infectious virus was detected only with APMV-3.
Thus, only APMV-1 strain BC and APMV-3 appeared to replicate
productively in these neuronal cell cultures.
Following intracerebral inoculation of 1-day-old chicks, only
APMV-1 strain BC, APMV-3, and (to a much lesser extent)
APMV-8 could be detected in brain tissue samples. With APMV-
1, virus neurotropism depends on the presence of a furin cleavage
site, since secretory proteases are unavailable in the brain [37].
The lack of neurotropism of the APMV-1 strain LaSota is
consistent with this idea. However, APMV-3 appears to be an
exception, since it lacks a furin site and is dependent on added
protease in cell culture and thus presumably dependent on
secreted protease in vivo, yet it replicated efficiently in the chick
brains and neutronal cells in vitro. Interestingly, however, while
APMV-3 was clearly neurotropic, it caused no disease or death
and thus was not neurovirulent. These findings indicate that the
simple paradigm that neurotropism depends on the presence of
a furin cleavage site does not hold for APMV-3. Furthermore, it
shows that neurotropism by an APMV does not necessarily confer
neurovirulence. Our previous study with replacement of the
APMV-2 F protein with that of APMV-1 BC suggested an
important role for the BC F protein in virus neurotropism,
neuroinvasiveness, and neurovirulence in 1-day-old chicks [38].
Based on the generally held model for APMV-1 pathogenesis, it
would have been reasonable to suggest that the presence of the
furin site in the BC F protein was the major determinant of the
observed neurotropism, neuroinvasiveness, and neurovirulence.
However, the present study challenges the predominant role for
the cleavage site, and suggests that other features of the F protein
may be involved in the observed neurotropism, neuroinvasiveness,
and neurovirulence. Evaluating the difference in the roles of the F
proteins in virus neurotropism versus neurovirulence may provide
information on these activities and may help design safer vaccines
for neurotropic pathogens.
We also evaluated replication, tropism, and pathogenesis
following intranasal infection in 1-day-old chicks and 2-week-old
chickens. In 1-day-old chickens, only the APMV-1 strain BC and
APMV-3 were able to spread to the brain and replicate,
demonstrating neuroinvasiveness and neurotropism. These two
viruses, plus APMV-1 strain LaSota, also were detected in the
spleen of 1-day-old chicks. Conversely, replication of the other
APMVs was mostly detected the in trachea of chicks, and the virus
titers were moderate.
In 2-week-old birds, at 4 dpi, infection of APMV-1 strain BC
was found in all of the tested tissues, including the brain, and
LaSota was detected in all of the tested tissues except the brain.
APMV-3 also was detected in all of the tested tissues including the
brain. Replication of the other APMVs was restricted to the
trachea and lungs. In general, virus titers in the 2-week-old
chickens were lower than in the 1-day-old chicks. By 10 dpi, no
virus could be detected in any of the tissues in any of the infected
chickens for any serotype by virus isolation, suggesting that the
virus was cleared from all tissues and disease was resolved,
indicating the self-limited nature of the infections.
Histopathology analysis of APMV-infected 2-week-old chickens
showed that infection by each of the APMVs, including APMV-5,
produced tracheitis and mild pathology that was mainly restricted
to the respiratory tract. Previous study with serologic assays in
chickens infected with APMVs demonstrated a good humoral
response on 14 dpi [39]. Thus, the birds indeed appeared to be
infected even thought the recovery of infectious virus was often
sporadic and low. A single APMV type, namely APMV-5, was not
detected by virus isolation or by immunohistochemistry in any of
the chickens in this study. However, the serologic assay of chickens
that had been inoculated with APMV-5 also showed the
development of virus specific antibodies detected by virus plaque
reduction neutralization assay [39], suggesting that infection had
occurred. This suggests a low level of virus replication in chickens.
Thus, although APMV-5 bears a furin cleavage site and can cause
100% mortality in budgerigars [25], it was completely avirulent
and replicated inefficiently in chickens. This is suggestive of a host
range difference that was not greatly ameliorated by the presence
of a multi-basic cleavage site.
Experimental infection of mallard ducks with APMVs indicated
that all APMV serotypes, including duck isolates, are avirulent in
ducks. Differences were observed in the replication of various
APMVs between chickens and ducks. For example, replication of
APMV-1 strain BC was low in ducks compared to its efficient
replication chickens, although APMV-1 has shown to infect
waterfowls, such as geese and Muscovy and Pekin ducks [40–42].
Several APMV serotypes (APMV-3, -8, and -9) did not replicate in
ducks, even though APMV-3 replicated well in chickens and the
APMV-9 strain had been isolated from ducks. In chickens,
APMV-4 poorly replicated in both 1-day-old and 2-week-old
chickens in our study. In addition, the virus has been shown to
induce low HI titers in chickens compared to other APMVs, which
was taken as evidence of a low level of replication of this virus in
chickens [26,39]. However, we detected replication of APMV-4 in
trachea and lungs of infected ducks, indicating its preference to
ducks from which this strain had been isolated.
moderate multifocal mucosal attenuation, and loss of tracheal alveolar
mucous glands. Lung sections (B) exhibit moderate, multifocal,
lymphocytic to lymphohistiocytic bronchitis with mild to moderate
perivascular and peribronchial interstitial inflammation and focal
perivascular cuffing with varying severity. The presence of antigens
for most APMVs was detected in the epithelial lining of trachea (C) and
in the epithelium surrounding the medium and small bronchi of the
lungs (D).
doi:10.1371/journal.pone.0034927.g007
Table 3. Replication of APMVs in 3-week-old ducks.
Virus Virus replication in embryonated eggs
a
Brain Trachea Lung Spleen
APMV-1 (BC) 0/3 3/3 2/3 0/3
APMV-1 (LaSota) 0/3 3/3 0/3 0/3
APMV-2 0/3 1/3 0/3 0/3
APMV-3 0/3 0/3 0/3 0/3
APMV-4 0/3 2/3 1/3 0/3
APMV-6 0/3 2/3 2/3 0/3
APMV-7 0/3 2/3 2/3 1/3
APMV-8 0/3 0/3 0/3 0/3
APMV-9 0/3 0/3 0/3 0/3
aGroups of 3-week-old ducks were inoculated with each virus by the intranasal
route. Three birds from each group were sacrificed on day 4, and tissues
samples (brain, trachea, lung, and spleen) were collected and homogenized. To
confirm the virus replication, each sample (100 ml) in the collected samples was
inoculated into three eggs, and allantoic fluids were collected on 3 dpi. Virus
replication was determined by hemagglutination assay. Note that APMV-5 was
not analyzed because it does not replicate in the allantoic cavity of chicken
eggs.
doi:10.1371/journal.pone.0034927.t003
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were avirulent in both chickens and ducks as well as in standard
international assays. Each of the APMV serotypes replicated to
low-to-moderate titers in the trachea of chickens, with APMV-3
having the highest titers. Among APMV types 2–9, only APMV3
replicated systemically and was neuroinvasive and neurotropic,
although not neurovirulent. The sequence of the F protein
cleavage site was not a reliable predictor of pathogenicity of
APMVs in chickens, indicating incongruity with the well-known
APMV-1 paradigm. For example, the systemic replication and
neurotropism of APMV-3 is inconsistent with its lack of a furin
cleavage site and dependence on exogenous trypsin for replication
in cell culture. As another example, several of the APMV
serotypes, including types 2, 4, 6, and 7, lacked a furin site, but
replication of these viruses in cell culture was not improved by the
addition of exogenous trypsin. As yet another example, APMV-5
was the only one of serotypes 2–9 to have a furin site, and yet it
replicated to only moderate levels in cell culture, and replication in
chickens could be detected only by seroconversion. Thus, the
paradigm from studies with APMV-1 that virulence and systemic
spread correlates with the presence of a furin site generally was not
observed with APMV serotypes 2–9. Reverse genetics for different
pathotypes of APMV-1 and for prototype strains of APMV-2, 3,
and -7 have been developed and used for studying determinants of
virus pathogenesis [38,43–45]. Further characterization of virus
replication and pathogenicity using reverse genetics will enhance
our understanding of overall APMV pathogenesis.
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